First Time Loading...

BioXcel Therapeutics Inc
NASDAQ:BTAI

Watchlist Manager
BioXcel Therapeutics Inc Logo
BioXcel Therapeutics Inc
NASDAQ:BTAI
Watchlist
Price: 2.06 USD -3.29% Market Closed
Updated: May 16, 2024

P/S
Price to Sales

39.4
Current
48.6
Median
8.2
Industry
Lower than median
Higher than industry value

Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.

P/S
39.4
=
Market Cap
69.3m
/
Revenue
1.8m
All Countries
Close

P/S Forward Multiples

Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/S
19
2-Years Forward
P/S
4.9
3-Years Forward
P/S
1.6

See Also

Discover More